Recce Pharmaceuticals Ltd (ASX:RCE)
Australia · Delayed Price · Currency is AUD 0.5950
-0.0200 (-3.25%)
Dec 8, 2025, 1:30 PM AEST
Recce Pharmaceuticals Market Cap
Recce Pharmaceuticals has a market cap or net worth of 177.85 million as of December 5, 2025. Its market cap has increased by 66.74% in one year.
Market Cap
177.85M
Enterprise Value
177.93M
Revenue
7.51M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.60
Market Cap Chart
Since January 15, 2016, Recce Pharmaceuticals's market cap has increased from 20.55M to 177.85M, an increase of 765.55%. That is a compound annual growth rate of 24.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 177.85M | 58.15% |
| Dec 31, 2024 | 112.46M | 3.19% |
| Dec 29, 2023 | 108.98M | -7.28% |
| Dec 30, 2022 | 117.53M | -34.34% |
| Dec 31, 2021 | 179.00M | -2.33% |
| Dec 31, 2020 | 183.27M | 279.76% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Jan 15, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 88.88B |
| Pro Medicus | 26.02B |
| Cochlear | 17.62B |
| Sonic Healthcare | 11.42B |
| Ramsay Health Care | 8.33B |
| Ansell | 5.14B |
| Telix Pharmaceuticals | 5.02B |
| Mesoblast | 3.41B |